Glycogen synthase kinase-3 as a key regulator of cognitive function. (6th March 2020)

• Record Type: Journal Article
• Authors: Fan, Xuhong; Zhao, Zhenyu; Wang, Deming; Xiao, Ji
• Is Part Of: Acta biochimica et biophysica Sinica. Volume 52:Number 3(2020)
• Page Start: 219
• Page End: 230
• Publication Date: 2020-03-06
• Subjects: GSK-3 -- cognitive function -- neuroinflammation -- neurogenesis -- synaptic plasticity; Biochemistry -- Periodicals; Biophysics -- Periodicals; 572.05
• DOI: 10.1093/abbs/gmz156
• Languages: English
• ISSNs: 1672-9145

Abstract

Abstract: Glycogen synthase kinase-3 (GSK-3) is a highly conserved and multifunctional serine/threonine protein kinase widely distributed in eukaryotic cells. GSK-3 is originally thought to be an enzyme that regulates glycogen synthesis. It was subsequently found that GSK-3 influences many critical cellular functions, such as cell structure, neural plasticity, gene expression, and neuronal survival. Recently, GSK-3 has been found to be associated with cognition, and its dysregulation leads to cognitive impairments in many diseases, including Alzheimer's disease, diabetes, depression, Parkinson's disease, and others. In this review, we summarized the current knowledge about the structure of GSK-3, the regulation of GSK-3 activity, and its role in cognitive function and cognitive-related disease.